Strittmatter v. Commissioner of Social Security Administration

District Court, N.D. Ohio·Decided January 17, 2023·No. 5:22-cv-00692·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION

CRYSTAL STRITTMATTER, ) CASE NO. 5:22-CV-00692 ) Plaintiff, ) ) v. ) MAGISTRATE JUDGE ) JONATHAN D. GREENBERG KILOLO KIJAKAZI, ) Commissioner of Social Security, ) ) MEMORANDUM OF OPINION Defendant. ) AND ORDER )

Plaintiff, Crystal Strittmatter (APlaintiff@ or AStrittmatter@), challenges the final decision of Defendant, Kilolo Kijakazi, Acting Commissioner of Social Security (ACommissioner@), denying her applications for Disability Insurance Benefits (ADIB@) under Titles II of the Social Security Act, 42 U.S.C. '' 416(i), 423, 1381 et seq. (AAct@). This Court has jurisdiction pursuant to 42 U.S.C. ' 405(g) and the consent of the parties, pursuant to 28 U.S.C. ' 636(c)(2). For the reasons set forth below, the Commissioner=s final decision is AFFIRMED.

1 I. PROCEDURAL HISTORY In April 2019, Strittmatter filed an application for DIB alleging a disability onset date of July 1, 2013, and alleging disability due to narcolepsy with cataplexy, depression, anxiety, sleep attacks, memory issues, concentration issues, obesity, fatigue, and pain. (Transcript (ATr.@) at 267.) Her applications were denied initially and upon reconsideration, and Strittmatter requested a hearing before an administrative law judge (AALJ@). (Tr. 118, 125, 219) On April 21, 2020, ALJ Paula Goodrich held a hearing, during which Strittmatter, represented by counsel (Chad Delesk), and an impartial vocational expert (AVE@) testified. (Tr. 60-110.) On July 8, 2020, the ALJ issued a written decision finding Plaintiff was not disabled. (Tr. 126-44). The ALJ=s decision became final on March 3, 2022, when the Appeals Council declined further review. (Tr. 1156) On April 29, 2022, Strittmatter filed her Complaint to challenge the Commissioner=s final decision. (Doc. No. 1.) The parties have completed briefing in this case. (Doc. Nos. 8, 10, 11). Strittmatter asserts the following assignment of error: (1) Whether the ALJ’s Step Three finding is supported by substantial evidence.

(Doc. No. 8 at 9). II. EVIDENCE A. Personal and Vocational Evidence Strittmatter was born in 1973 and was forty-seven years old at the time of her administrative hearing, making her a Ayounger@ person under social security regulations. (Tr. 112.) See 20 C.F.R. '' 404.1563(c). She has at least a high school education and is able to communicate in English. (Tr. 117) She has past relevant work as an insurance clerk. (Tr. 137.)

2 B. R elevant Medical Evidence1 On October 27, 2010, Strittmatter treated with board-certified sleep specialist Frankie R. Roman, M.D., who diagnosed narcolepsy with cataplexy. (Tr. 383) Strittmatter attended medication management appointments with Dr. Roman. (Tr. 369-80). In December 2012, her medications were listed as Vyanase, Ritalin, dextroamphetamine, and Xyrem. (Id.) In July 2013, Strittmatter was hospitalized at Summa Health System for stroke-like syndrome with left-sided hemiplegia. (Tr. 426) She indicated, at that time, that she had a history of narcolepsy and had been on mediation for narcolepsy for many years. (Tr. 625) The attending physician noted that, “it was really difficult to tell” whether her symptoms were a result of her narcolepsy medications, specifically amphetamines. (Id.) After speaking with Dr. Roman, it was decided to “hold her amphetamines at this time as they do portend a higher risk of stroke and MI.” (Tr. 452) When Strittmatter returned to Dr. Roman in March 2014, it was noted that she had been off her narcolepsy medications for seven months. (Tr. 403) She reported struggling with excessive daytime sleepiness, poor attention span and concentration, and increased cataplectic attacks. (Id.) She also stated

that her quality of life had deteriorated significantly. (Id.) Dr. Roman restarted her on Xyrem. (Id.) In February 2015, Strittmatter reported that she had not been on medication for her narcolepsy since July 2014. (Tr. 749) She reported the Xyrem was “effective,” but required a neurologist to provide it, and she was no longer seeing Dr. Roman. (Id.) In April 2015, Strittmatter reported she was still seeking a neurologist. (Tr. 740) In May 2015, Strittmatter reported that she was not currently taking any medication for narcolepsy and had no residual deficits from her stroke. (Tr. 509) In January 2016, it was

1 The Court’s recitation of the medical evidence is not intended to be exhaustive and is limited to the evidence cited in the parties= Briefs.

3 again noted that Strittmatter was “not currently on treatment” for her narcolepsy. (Tr. 710) At that appointment Strittmatter exhibited a left eye “twitch.” (Tr. 711) The remainder of her neurological tests were unremarkable. (Id.) On November 19, 2016, Strittmatter reported chronic fatigue secondary to narcolepsy and it was noted that her narcolepsy without cataplexy was “doing well.” (Tr. 662). On October 17, 2019, neurologist Dr. Ewing-Wilson administered a MSLT that yielded abnormal results consistent with a diagnosis of narcolepsy (Tr. 904). Test results noted that Strittmatter should not drive or operate heavy machinery when sleepy and that “wake-promoting medications may be indicated.” (Id.) C. Medical Opinions In June 2019, non-examining State agency consultants Drs. Green and Warren reviewed Strittmatter’s file and determined that (a) insufficient evidence existed to determine functional effects of her mental health impairment, (b) she did not meet Listing 11.22, Motor Neuron Disorders Other than ALS; and (c) she retained the residual functional capacity (RFC) to complete work with the following exertional limitations: occasional lifting/carrying 20 pounds; frequent lifting/carrying 10 pounds; standing/walking/sitting for 6 hours in an 8 hour workday; avoiding hazard exposure; and no climbing ladders, ropes, or scaffolds. (Tr. 115-16). On reconsideration, in August 2019, non-examining State agency consultants Drs. Teague and Zeune affirmed the June 2019 opinions. (Tr. 120-25) D. Hearing Testimony During the April 21, 2020, hearing, Strittmatter testified to the following: e Strittmatter testified that narcolepsy was her biggest medical concern. She believed she was originally diagnosed with narcolepsy in 2005 and started medication at that time. Strittmatter stated she had a stroke in 2013 and, at that time, it was determined to take her off the amphetamines she used to treat her narcolepsy. Prior to her stroke, she felt the narcolepsy medication had been helpful. Strittmatter stated that she discontinued taking the only medication

Free access — add to your briefcase to read the full text and ask questions with AI

Strittmatter v. Commissioner of Social Security Administration, (N.D. Ohio 2023).

Strittmatter v. Commissioner of Social Security Administration (Strittmatter v. Commissioner of Social Security Administration) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Sullivan v. Zebley
493 U.S. 521 (Supreme Court, 1990)
Yer Her v. Commissioner of Social Security
203 F.3d 388 (Sixth Circuit, 1999)
Ruby E. Heston v. Commissioner of Social Security
245 F.3d 528 (Sixth Circuit, 2001)
Theresa E. Foster v. William A. Halter
279 F.3d 348 (Sixth Circuit, 2002)
David Bowen v. Commissioner of Social Security
478 F.3d 742 (Sixth Circuit, 2007)
Debra Rogers v. Commissioner of Social Security
486 F.3d 234 (Sixth Circuit, 2007)
Beth Lee v. Commissioner of Social Security
529 F. App'x 706 (Sixth Circuit, 2013)
Ealy v. Commissioner of Social Security
594 F.3d 504 (Sixth Circuit, 2010)
White v. Commissioner of Social Security
572 F.3d 272 (Sixth Circuit, 2009)
Fleischer v. Astrue
774 F. Supp. 2d 875 (N.D. Ohio, 2011)
Sheeks v. Commissioner of Social Security Administration
544 F. App'x 639 (Sixth Circuit, 2013)
Kimberly Smith-Johnson v. Comm'r of Social Security
579 F. App'x 426 (Sixth Circuit, 2014)